Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease. - Fleisher AS; Munsie LM; Perahia DGS; Andersen SW; Higgins IA; Hauck PM; Lo AC; Sims JR; Brys M; Mintun M (Neurology, 2024)